John N. Lilly serves as Executive at Adams Respiratory Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, John N. Lilly has executed 13 insider transactions totaling $30.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 29, 2008 involved selling 3,038 shares valued at $182.3K.
John N. Lilly currently holds 3,038 shares of Adams Respiratory Therapeutics, Inc. (ARXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John N. Lilly has been a net buyer of ARXT stock. They have purchased $30.1K and sold $0 worth of shares.
John N. Lilly's most recent insider trade was on Jan 29, 2008, when they sold 3,038 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted
| 1,850 |
| $60.00 |
| Discretionary |
| Jan 2, 2008 | ARXT | $0 | Award | 210 | $N/A | Discretionary |
| Oct 1, 2007 | ARXT | $0 | Award | 323 | $N/A | Discretionary |
| Oct 1, 2007 | ARXT | $0 | Award | 323 | $N/A | Discretionary |
| Jul 2, 2007 | ARXT | $0 | Award | 316 | $N/A | Discretionary |
| Apr 2, 2007 | ARXT | $0 | Award | 374 | $N/A | Discretionary |
| Jan 3, 2007 | ARXT | $0 | Award | 300 | $N/A | Discretionary |
| Nov 14, 2006 | ARXT | $30.1K | Purchase | 700 | $42.94 | Discretionary |
| Oct 2, 2006 | ARXT | $0 | Award | 356 | $N/A | Discretionary |
| Jul 13, 2006 | ARXT | $0 | Award | 294 | $N/A | Discretionary |
| Apr 1, 2006 | ARXT | $0 | Award | 315 | $N/A | Discretionary |
| Jan 1, 2006 | ARXT | $0 | Award | 308 | $N/A | Discretionary |